Phathom Pharmaceuticals

PHATNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$627.791 M

$7.76 +4.16%

Close of 22 Sept 2026

Revenue

$175.1M

#2334 by revenue

Earnings

-$221.3K

Loss-making

Shares outstanding

80,900,934

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#191Monopar TherapeuticsMNPR$648.6M
#192CytomX TherapeuticsCTMX$640.6M
#193Phathom PharmaceuticalsPHAT$627.8M
#194Aquestive TherapeuticsAQST$621.3M
#195OculisOCS$621.0M

What if Phathom Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$373,715.95

Per share 48,159× higher

Bitcoin $1.74T

$21,528.24

Per share 2,774× higher

Nvidia $5.52T

$68,179.27

Per share 8,786× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Phathom Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.